Literature DB >> 19120897

Relationships between Helicobacter pylori infection status, endoscopic, histopathological findings, and cytokine production in the duodenum of Crohn's disease patients.

Takafumi Ando1, Osamu Watanabe, Kazuhiro Ishiguro, Osamu Maeda, Daisuke Ishikawa, Masaaki Minami, Motofusa Hasegawa, Shinya Kondo, Yasuyuki Goto, Naoki Ohmiya, Yasumasa Niwa, Hidemi Goto.   

Abstract

BACKGROUND: The chronic inflammatory process in patients with Crohn's disease (CD) may affect any part of the gastrointestinal (GI) tract. The pathogenesis of CD involves immunological abnormalities, including deficient or excessive expression of cytokines. We examined Helicobacter pylori infection status, endoscopic and histopathological findings, and cytokine production in the duodenum of CD patients in comparison with controls.
METHODS: Thirty-eight CD patients underwent diagnostic upper GI endoscopy. Twelve age- and sex-matched health checkup examinees were used as controls. H. pylori infection status was assessed by the (13)C-urea breath test. At the time of endoscopy, two biopsy specimens each were obtained from the second portion of the duodenum, one for hematoxylin-eosin staining and immunohistochemical analysis with anti-CD68 antibody, and one for in vitro organ culture. Interleukin (IL)-6 and -8 levels were measured in organ culture supernatant by enzyme-linked immunosorbent assay.
RESULTS: H. pylori infection was significantly (P<0.05) more frequent in controls (42%) than in CD patients (8%). In the duodenum, erosions or ulcers were more frequent in CD patients (53%) than in controls (8%). Mononuclear cell infiltration in the duodenum was more severe in CD patients than in controls and IL-6 production was higher, whereas IL-8 production showed no significant difference. CD68+ cells in the duodenum were more prominent in CD patients than in controls.
CONCLUSIONS: H. pylori infection is unlikely in CD patients, but they show immunological abnormalities in the duodenum, possibly from innate immune responses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19120897     DOI: 10.1111/j.1440-1746.2008.05438.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  7 in total

1.  Aggressive Helicobacter pylori-negative peptic ulceration as the initial manifestation of Crohn's disease.

Authors:  James Callaghan; Sarah Brown; Tim Battcock; Sally Parry; Jonathon Snook
Journal:  Frontline Gastroenterol       Date:  2012-05-01

2.  The relationship between inflammatory bowel disease and Helicobacter pylori across East Asian, European and Mediterranean countries: a meta-analysis.

Authors:  Rabbiaatul Addawiyah Imawana; Daniel Robert Smith; Michaela Louise Goodson
Journal:  Ann Gastroenterol       Date:  2020-06-06

Review 3.  Helicobacter pylori infection and inflammatory bowel disease in Asians: a meta-analysis.

Authors:  Xiao-Wei Wu; Hong-Zan Ji; Miao-Fang Yang; Lin Wu; Fang-Yu Wang
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

Review 4.  Helicobacter pylori infection and inflammatory bowel disease: is there a link?

Authors:  Konstantinos Papamichael; Panagiotis Konstantopoulos; Gerassimos J Mantzaris
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

5.  Diagnosis of Helicobacter Pylori Infection is Associated with Lower Prevalence and Subsequent Incidence of Crohn's Disease.

Authors:  Lars E Bartels; Peter Jepsen; Lisbet A Christensen; Lars U Gerdes; Hendrik Vilstrup; Jens F Dahlerup
Journal:  J Crohns Colitis       Date:  2015-12-16       Impact factor: 9.071

6.  The association between Helicobacter pylori infection and inflammatory bowel disease based on meta-analysis.

Authors:  T Rokkas; J P Gisbert; Y Niv; C O'Morain
Journal:  United European Gastroenterol J       Date:  2015-12       Impact factor: 4.623

7.  Helicobacter pylori is Associated with Less Fistulizing, Stricturing, and Active Colitis in Crohn's Disease Patients.

Authors:  Andre Fialho; Andrea Fialho; Ammar Nassri; Valery Muenyi; Miguel Malespin; Bo Shen; Silvio W De Melo
Journal:  Cureus       Date:  2019-11-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.